Letter: lipid-lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B-more evidence is needed. Authors' reply

Aliment Pharmacol Ther. 2017 Oct;46(8):770-771. doi: 10.1111/apt.14282.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenine
  • Hepatitis B e Antigens
  • Hepatitis B, Chronic*
  • Humans
  • Lipids
  • Organophosphonates
  • Tenofovir*

Substances

  • Hepatitis B e Antigens
  • Lipids
  • Organophosphonates
  • Tenofovir
  • Adenine